Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists

NCT05338632 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Opioid Induced Respiratory Depression
Chronic Opioid Use

Interventions

DRUG: Narcan 40 MG/ML Nasal Spray
DRUG: Naloxone Hydrochloride
DRUG: Nalmefene HCl injection

Sponsor

Leiden University Medical Center

Collaborators

[object Object]